How often do you update the Dare stock price projections?
"DARE" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "DARE" projections. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Dare Bioscience Inc.
Is the Dare share a good investment?
Our Ai stock analyst implies that there will be a negative trend in the future and the DARE shares are not a good investment for making money. Since this share has a negative outlook we recommend looking for other projects instead to build a portfolio.
Will the Dare Bioscience stock price drop or rise?
Yes. The Dare Bioscience stock price may drop from 1.765 USD to 1.539 USD . The change will be -12.782 %. Will DARE stock price grow / rise / go up?
What does Daré Bioscience do?
Sign-up to receive the latest news and ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health.
Will DARE stock go up?
The 4 analysts offering 12-month price forecasts for Dare Bioscience Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +296.83% increase from the last price of 1.26.
Is DARE a buy or sell?
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 7.34, which is an increase of 501.64% from the latest price.
Is DARE stock undervalued?
Fair Value of DARE stock based on Discounted Cash Flow (DCF) DARE ($1.35) is significantly undervalued...
Is DARE stock a good buy?
Out of 2 analysts, 1 (50%) are recommending DARE as a Strong Buy, 1 (50%) are recommending DARE as a Buy, 0 (0%) are recommending DARE as a Hold, 0 (0%) are recommending DARE as a Sell, and 0 (0%) are recommending DARE as a Strong Sell. What is DARE's earnings growth forecast for 2022-2024?
What is the latest news on DARE stock?
(DARE) Reports Q4 Loss, Misses Revenue Estimates. Dare Bioscience, Inc. (DARE) delivered earnings and revenue surprises of 14.29% and 100%, respectively, for the quarter ended December 2021.
What is target dare price?
Stock Price TargetsHigh$17.00Median$6.00Low$3.00Average$7.20Current Price$1.3500
When was DARE Stock FDA approved?
Dec 7, 2021Development Timeline for XaciatoDateArticleDec 7, 2021Approval FDA Approves Xaciato (clindamycin phosphate) Vaginal Gel as a Treatment for Bacterial VaginosisAug 9, 2021Daré Bioscience Announces FDA Acceptance and Priority Review of New Drug Application for DARE-BV1 for the Treatment of Bacterial Vaginosis3 more rows•Dec 8, 2021
What does dare Bioscience do?
Dare Bioscience, Inc. operates as a healthcare company. The Company offers women's reproductive health devices, therapeutics, and diagnostics. Dare Bioscience provides contraception, vaginal health, pain, and fertility products.
What is the latest news in Dare Bioscience?
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates. Dare Bioscience, Inc. (DARE) delivered earnings and revenue surprises of 14.29% and 100%, respectively, for the quarter ended December 2021.
Should I buy or sell Daré Bioscience stock right now?
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Daré Bioscience in the last year. There are currently 4 buy ratin...
What is Daré Bioscience's stock price forecast for 2022?
4 brokerages have issued 1 year price targets for Daré Bioscience's stock. Their forecasts range from $4.00 to $17.00. On average, they expect Daré...
How has Daré Bioscience's stock price performed in 2022?
Daré Bioscience's stock was trading at $2.00 at the beginning of the year. Since then, DARE stock has decreased by 36.5% and is now trading at $1.2...
Are investors shorting Daré Bioscience?
Daré Bioscience saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 1,950,000 shares, a decline...
When is Daré Bioscience's next earnings date?
Daré Bioscience is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Dar...
How were Daré Bioscience's earnings last quarter?
Daré Bioscience, Inc. (NASDAQ:DARE) announced its quarterly earnings data on Thursday, May, 12th. The biotechnology company reported ($0.10) earnin...
Who are Daré Bioscience's key executives?
Daré Bioscience's management team includes the following people: Ms. Sabrina Martucci Johnson , Pres, CEO, Sec. & Director (Age 55, Pay $643.48k...
Who are some of Daré Bioscience's key competitors?
Some companies that are related to Daré Bioscience include Janux Therapeutics (JANX) , Tango Therapeutics (TNGX) , Day One Biopharmaceuticals (D...
What other stocks do shareholders of Daré Bioscience own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Daré Bioscience investors own include FuelCell Energy (FCE...
"Should I invest in Dare Bioscience stock?" "Should I trade "DARE" stock today?"
According to our live Forecast System, Dare Bioscience Inc stock is a bad long-term (1-year) inves...
What is the Dare Bioscience stock price / share price today?
The Dare Bioscience stock price is 1.360 USD today.
Will DARE stock price drop / fall?
Yes. The Dare Bioscience stock price may drop from 1.360 USD to 1.305...
Will DARE stock price grow / rise / go up?
No. See above .
Will DARE stock price crash?
According to our analysis, this can happen.
Will Dare Bioscience stock price hit 10 USD price in a year?
Not within a year. See above .
Will Dare Bioscience stock price hit 20 USD price in a year?
Not within a year. See above .
Will Dare Bioscience stock price hit 50 USD price in a year?
Not within a year. See above .
About Daré Bioscience
Daré Bioscience (NASDAQ:DARE) Frequently Asked Questions
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L.
Signals & Forecast
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Daré Bioscience in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Daré Bioscience stock. View analyst ratings for Daré Bioscience or view top-rated stocks.
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Wednesday, February 23, 2022, and so far it has risen 3.47%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Daré Bioscience, Inc.
Is Daré Bioscience, Inc. stock A Buy?
Daré Bioscience, Inc. finds support from accumulated volume at $1.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are very positive as most new trades are buy in Daré Bioscience, Inc
Daré Bioscience, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Golden Star Signal
In the last 100 trades there were 7.83 million shares bought . The last trade was done 34 days ago by Walters-hoffert Lisa who bough 185 thousand shares. For the period there is more stocks sold than bought, but the most of the latest transactions are buy. This can indicate renewed interest by the insider, but also stock options expiring
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
